m+Medelevator.RU
← Поиск публикаций
MedComm · 2026

CD8+ Tissue-Resident Memory T Cells in Health and Disease.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ai Yu-Han, Xu Ting-Ting, Lin Sen, Xiao Meng-Yu, Lin Yun-Xia, Ma Hao-Wen, Liu Yue-Yang, Wang Yao-Jie, Yin Lu-Ning, Huang Mei, Liu Yong-Da, Zhu Chao, Zhu Xiao-Ting, Yuan Ji-Hang

Аннотация

CD8+ tissue-resident memory T (TRM) cells play a pivotal role in local immune regulation. These noncirculating T cells are uniquely positioned to orchestrate rapid site-specific immune responses, making them central to understanding tissue-specific immunity. Prior work has demonstrated that CD8+ TRM cells possess dual functions: they are essential for immune defense against pathogens and malignancies, yet also drive pathological inflammation in autoimmune disorders. Furthermore, emerging evidence has begun to elucidate the intrinsic molecular mechanisms controlling this functional duality and to develop intervention strategies for its precise modulation. Here, we review current knowledge of the origin, transcriptional regulation, phenotypic characteristics, and functions of CD8+ TRM cells. We discuss how TRM cells correlate with clinical outcomes in diverse cancer types. Furthermore, we explore immune checkpoint inhibitors and other immunotherapies that target TRM cells and their therapeutic implications from preclinical and translational human research. This review provides a comprehensive understanding of the molecular and cellular mechanisms governing TRM cell activity and details their roles in health and disease. Ultimately, the framework of tissue immune networks reveals that leveraging TRM cell development, tissue residency, and metabolism processes enables the design of innovative treatments for these diseases.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты